BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35460832)

  • 1. Suboptimal folic acid exposure rewires oncogenic metabolism and proteomics signatures to mediate human breast cancer malignancy.
    Huang A; Huang SY; Shah P; Ku WC; Huang KT; Liu YF; Su CL; Huang RS
    J Nutr Biochem; 2022 Aug; 106():109000. PubMed ID: 35460832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-folate stress reprograms cancer stem cell-like potentials and bioenergetics metabolism through activation of mTOR signaling pathway to promote in vitro invasion and in vivo tumorigenicity of lung cancers.
    Chen WJ; Huang RS
    J Nutr Biochem; 2018 Mar; 53():28-38. PubMed ID: 29190547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis.
    Wen ZH; Su YC; Lai PL; Zhang Y; Xu YF; Zhao A; Yao GY; Jia CH; Lin J; Xu S; Wang L; Wang XK; Liu AL; Jiang Y; Dai YF; Bai XC
    Oncogene; 2013 Jan; 32(2):160-70. PubMed ID: 22349822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity.
    Martin EC; Rhodes LV; Elliott S; Krebs AE; Nephew KP; Flemington EK; Collins-Burow BM; Burow ME
    Mol Cancer; 2014 Oct; 13():229. PubMed ID: 25283550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
    Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
    PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Proteomics Identifies Acinus L as a Direct Insulin- and Amino Acid-Dependent Mammalian Target of Rapamycin Complex 1 (mTORC1) Substrate.
    Schwarz JJ; Wiese H; Tölle RC; Zarei M; Dengjel J; Warscheid B; Thedieck K
    Mol Cell Proteomics; 2015 Aug; 14(8):2042-55. PubMed ID: 25907765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular regulation of apoptotic machinery and lipid metabolism by mTORC1/mTORC2 dual inhibitors in preclinical models of HER2+/PIK3CAmut breast cancer.
    Qian J; Chen Y; Meng T; Ma L; Meng L; Wang X; Yu T; Zask A; Shen J; Yu K
    Oncotarget; 2016 Oct; 7(41):67071-67086. PubMed ID: 27563814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-crystallin B chains in trastuzumab-resistant breast cancer cells promote endothelial cell tube formation through activating mTOR.
    Yang L; Higashisaka K; Shimoda M; Haga Y; Sekine N; Tsujino H; Nagano K; Shimazu K; Tsutsumi Y
    Biochem Biophys Res Commun; 2022 Jan; 588():175-181. PubMed ID: 34959190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms.
    Wilson-Edell KA; Yevtushenko MA; Rothschild DE; Rogers AN; Benz CC
    Breast Cancer Res Treat; 2014 Apr; 144(2):287-298. PubMed ID: 24562770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
    Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
    Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional control of cellular metabolism by mTOR signaling.
    Yecies JL; Manning BD
    Cancer Res; 2011 Apr; 71(8):2815-20. PubMed ID: 21487041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian target of rapamycin (mTOR) inhibition with rapamycin improves cardiac function in type 2 diabetic mice: potential role of attenuated oxidative stress and altered contractile protein expression.
    Das A; Durrant D; Koka S; Salloum FN; Xi L; Kukreja RC
    J Biol Chem; 2014 Feb; 289(7):4145-60. PubMed ID: 24371138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling.
    Gao G; Chen W; Yan M; Liu J; Luo H; Wang C; Yang P
    Int J Mol Med; 2020 Jan; 45(1):195-209. PubMed ID: 31746373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Pan S; Liu H; Gao F; Luo H; Lin H; Meng L; Jiang C; Guo Y; Chi J; Guo H
    J Cell Mol Med; 2018 Jun; 22(6):3183-3191. PubMed ID: 29571225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Colomer R; Brunet J; Menendez JA
    Ann Oncol; 2008 Jun; 19(6):1097-109. PubMed ID: 18283037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression.
    Hall BA; Kim TY; Skor MN; Conzen SD
    Breast Cancer Res Treat; 2012 Sep; 135(2):469-79. PubMed ID: 22842983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo.
    Zhang Y; Xu S; Lin J; Yao G; Han Z; Liang B; Zou Z; Chen Z; Song Q; Dai Y; Gao T; Liu A; Bai X
    Breast Cancer Res Treat; 2012 Nov; 136(2):379-88. PubMed ID: 23053656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDK4 protein promotes tumorigenesis through activation of cAMP-response element-binding protein (CREB)-Ras homolog enriched in brain (RHEB)-mTORC1 signaling cascade.
    Liu Z; Chen X; Wang Y; Peng H; Wang Y; Jing Y; Zhang H
    J Biol Chem; 2014 Oct; 289(43):29739-49. PubMed ID: 25164809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTORC1 is a critical mediator of oncogenic Semaphorin3A signaling.
    Yamada D; Kawahara K; Maeda T
    Biochem Biophys Res Commun; 2016 Aug; 476(4):475-480. PubMed ID: 27246732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo.
    Shrivastav A; Bruce M; Jaksic D; Bader T; Seekallu S; Penner C; Nugent Z; Watson P; Murphy L
    Breast Cancer Res; 2014 May; 16(3):R49. PubMed ID: 24887419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.